The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Epidemiology of Hepatocellular Carcinoma
Open accessAbstract
Liver cancer is a major contributor to the worldwide cancer burden. Incidence rates of this disease have increased in many countries in recent decades. As the principal histologic type of liver cancer, hepatocellular carcinoma (HCC) accounts for the great majority of liver cancer diagnoses and deaths. Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain, at present, the most important global risk factors for HCC, but their importance will likely decline in the coming years. The effect of HBV vaccination of newborns, already seen in young adults in some countries, will be more notable as vaccinated cohorts age. In addition, effective treatments for chronic infections with both HBV and HCV should contribute to declines in the rates of viral‐associated HCC. Unfortunately, the prevalence of metabolic risk factors for HCC, including metabolic syndrome, obesity, type II diabetes and non‐alcoholic fatty liver disease (NAFLD) are increasing and may jointly become the major cause of HCC globally. Excessive alcohol consumption also remains an intractable risk factor, as does aflatoxin contamination of food crops in some parts of the world. While significant efforts in early diagnosis and better treatment are certainly needed for HCC, primary prevention efforts aimed at decreasing the prevalence of obesity and diabetes and controlling mycotoxin growth, are just as urgently required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Self-citationVernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Bagnardi, V, Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V, Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.579 · Cited by 1,342
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220205 · Cited by 1,328
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Self-citationContemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,150
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Self-citationGlobal Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Self-citationDavis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Self-citationOverall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42.
(1987) · PubMed · Cited by 851
Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795
Self-citationWong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., Akuta, N., Suzuki, Y., Saitoh, S., Arase, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26180 · Cited by 710
Yang, H.-I., Yuen, M.-F., Chan, H. L.-Y., Han, K.-H., Chen, P.-J., Kim, D.-Y., Ahn, S.-H., Chen, C.-J., Wong, V. W.-S., & Seto, W.-K. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70077-8 · Cited by 669
Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
El-Serag, H. B., & Kanwal, F. (2014) · Hepatology · doi:10.1002/hep.27222 · Cited by 646
Self-citationMarrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., Heimbach, J. K., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.802 · Cited by 645
International trends in hepatocellular carcinoma incidence, 1978–2012
Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., Ferlay, J., Valery, P. C., Bray, F., & McGlynn, K. A. (2020) · International Journal of Cancer · doi:10.1002/ijc.32723 · Cited by 594
Self-citationIoannou, G. N., Green, P. K., & Berry, K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.030 · Cited by 573
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Singal, A. G., & El-Serag, H. B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.014 · Cited by 530
Self-citation(2012) · PubMed Central · Cited by 502
Waziry, R., Hajarizadeh, B., Grebely, J., Amin, J., Law, M., Danta, M., George, J., & Dore, G. J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.025 · Cited by 500
Papatheodoridis, G. V., Lampertico, P., Manolakopoulos, S., & Lok, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.035 · Cited by 459
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
Petrick, J. L., Kelly, S. P., Altekruse, S. F., McGlynn, K. A., & Rosenberg, P. S. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7412 · Cited by 442
Self-citationMetformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G. F. M., Pellegrini, F., & Nicolucci, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071583 · Cited by 428
Kumar, V., Kato, N., Urabe, Y., Takahashi, A., Muroyama, R., Hosono, N., Otsuka, M., Tateishi, R., Omata, M., Nakagawa, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.809 · Cited by 377
Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis
Liu, Y., Chang, C.-C. H., Marsh, G. M., & Wu, F. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.009 · Cited by 372
Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
Maucort‐Boulch, D., de Martel, C., Franceschi, S., & Plummer, M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31280 · Cited by 358
Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., et al. (2010) · Nature Genetics · doi:10.1038/ng.638 · Cited by 346
Udomkun, P., Wiredu, A. N., Nagle, M., Müller, J., Vanlauwe, B., & Bandyopadhyay, R. (2017) · Food Control · doi:10.1016/j.foodcont.2017.01.008 · Cited by 343
Chhatwal, J., Kanwal, F., Roberts, M. S., & Dunn, M. A. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1336 · Cited by 338
Projections of primary liver cancer to 2030 in 30 countries worldwide
Valery, P. C., Laversanne, M., Clark, P. J., Petrick, J. L., McGlynn, K. A., & Bray, F. (2018) · Hepatology · doi:10.1002/hep.29498 · Cited by 330
Self-citationNonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.5 · Cited by 320
Kanwal, F., Kramer, J. R., Li, L., Dai, J., Natarajan, Y., Yu, X., Asch, S. M., & El‐Serag, H. B. (2020) · Hepatology · doi:10.1002/hep.31014 · Cited by 319
Wu, C.-Y., Lin, J.-T., Ho, H. J., Su, C.-W., Lee, T.-Y., Wang, S.-Y., Wu, C., & Wu, J.-C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.048 · Cited by 319
Jiang, D.-K., Sun, J., Cao, G., Liu, Y., Lin, D., Gao, Y.-Z., Ren, W.-H., Long, X.-D., Zhang, H., Ma, X.-P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2483 · Cited by 309
Papatheodoridis, G. V., Idilman, R., Dalekos, G. N., Buti, M., Chi, H., van Boemmel, F., Calleja, J. L., Sypsa, V., Goulis, J., Manolakopoulos, S., et al. (2017) · Hepatology · doi:10.1002/hep.29320 · Cited by 301
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Yang, J. D., Mohamed, E. A., Aziz, A. O. A., Shousha, H. I., Hashem, M. B., Nabeel, M. M., Abdelmaksoud, A. H., Elbaz, T. M., Afihene, M. Y., Duduyemi, B. M., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30161-3 · Cited by 278
Kanwal, F., Kramer, J. R., Asch, S. M., Cao, Y., Li, L., & El‐Serag, H. B. (2020) · Hepatology · doi:10.1002/hep.30823 · Cited by 277
Self-citationAlberg, A. J., Shopland, D. R., & Cummings, K. M. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt335 · Cited by 267
Golabi, P., Fazel, S., Otgonsuren, M., Sayiner, M., Locklear, C. T., & Younossi, Z. M. (2017) · Medicine · doi:10.1097/md.0000000000005904 · Cited by 257
Petrick, J. L., Campbell, P. T., Koshiol, J., Thistle, J. E., Andreotti, G., Beane-Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Doody, M. M., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0007-z · Cited by 257
Self-citationThirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chiang, C.-J., Yang, Y.-W., You, S.-L., Lai, M.-S., & Chen, C.-J. (2013) · JAMA · doi:10.1001/jama.2013.276701 · Cited by 247
Hepatic Iron Overload and Hepatocellular Carcinoma
Kew, M. C. (2014) · Liver Cancer · doi:10.1159/000343856 · Cited by 239
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., Corrao, G., Boffetta, P., & La Vecchia, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu020 · Cited by 229
Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.-X., Foo, J. N., McLaren, P. J., Li, Z., Yang, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002791 · Cited by 210
Ohkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188
Schlesinger, S., Aleksandrova, K., Pischon, T., Fedirko, V., Jenab, M., Trepo, E., Boffetta, P., Dahm, C. C., Overvad, K., Tjønneland, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27645 · Cited by 185
Miki, D., Ochi, H., Hayes, C. N., Abe, H., Yoshima, T., Aikata, H., Ikeda, K., Kumada, H., Toyota, J., Morizono, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.876 · Cited by 177
Hsu, Y.-C., Yip, T. C.-F., Ho, H. J., Wong, V. W.-S., Huang, Y.-T., El-Serag, H. B., Lee, T.-Y., Wu, M.-S., Lin, J.-T., Wong, G. L.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.032 · Cited by 176
Self-citationBody Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults
Campbell, P. T., Newton, C. C., Freedman, N. D., Koshiol, J. E., Alavanja, M. C. R., Freeman, L. E. B., Buring, J. E., Chan, A. T., Chong, D. Q., Datta, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0787 · Cited by 165
Self-citationReduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China
Chen, J.-G., Egner, P. A., Ng, D., Jacobson, L. P., Muñoz, A., Zhu, Y.-R., Qian, G.-S., Wu, F., Yuan, J.-M., Groopman, J. D., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0168 · Cited by 164
Kennedy, O. J., Roderick, P., Buchanan, R., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013739 · Cited by 163
Clifford, R., Zhang, J., Meerzaman, D. M., Lyu, M. S., Hu, Y., Cultraro, C. M., Finney, R. P., Kelley, J. M., Efroni, S., Greenblum, S. I., et al. (2010) · Hepatology · doi:10.1002/hep.23943 · Cited by 155
Gordeuk, V., McLaren, C., MacPhail, A., Deichsel, G., & Bothwell, T. (1996) · Blood · doi:10.1182/blood.v87.8.3470.bloodjournal8783470 · Cited by 154
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Zhang, H., Gao, C., Fang, L., Zhao, H.-C., & Yao, S. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.719926 · Cited by 148
Jinjuvadia, R., Patel, S., & Liangpunsakul, S. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a030c4 · Cited by 145
Gordon, S. C., Lamerato, L. E., Rupp, L. B., Li, J., Holmberg, S. D., Moorman, A. C., Spradling, P. R., Teshale, E. H., Vijayadeva, V., Boscarino, J. A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.062 · Cited by 143
Body mass index in childhood and adult risk of primary liver cancer
Berentzen, T. L., Gamborg, M., Holst, C., Sørensen, T. I. A., & Baker, J. L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.015 · Cited by 140
Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma
Hassan, M. M., Abdel-Wahab, R., Kaseb, A., Shalaby, A., Phan, A. T., El-Serag, H. B., Hawk, E., Morris, J., Singh Raghav, K. P., Lee, J.-S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.044 · Cited by 110
Dai, G., Liu, P., Li, X., Zhou, X., & He, S. (2019) · Medicine · doi:10.1097/md.0000000000014324 · Cited by 101
Sun, Z., Chen, T., Thorgeirsson, S. S., Zhan, Q., Chen, J., Park, J., Lu, P., Hsia, C. C., Wang, N.-J., Xu, L., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt007 · Cited by 99
Hagström, H., Tynelius, P., & Rasmussen, F. E. (2017) · Gut · doi:10.1136/gutjnl-2016-313622 · Cited by 98
Huang, A. C., Mehta, N. J., Dodge, J. L., Yao, F. Y., & Terrault, N. A. (2018) · Hepatology · doi:10.1002/hep.29855 · Cited by 96
Statins and primary liver cancer: a meta-analysis of observational studies
Pradelli, D., Soranna, D., Scotti, L., Zambon, A., Catapano, A. L., Mancia, G., Vecchia, C. L., & Corrao, G. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328358761a · Cited by 83
Álvarez, C. S., Graubard, B. I., Thistle, J. E., Petrick, J. L., & McGlynn, K. A. (2019) · Hepatology · doi:10.1002/hep.31040 · Cited by 77
Self-citationChang, K., Wu, Y.-Y., Hung, C., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.564 · Cited by 75
Jin, F., Xiong, W.-J., Jing, J.-C., Feng, Z., Qu, L., & Shen, X. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0970-0 · Cited by 68
Is It Time to Write a Prescription for Coffee? Coffee and Liver Disease
Torres, D. M., & Harrison, S. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.015 · Cited by 58
Hsu, Y., Wu, C., Lane, H.-Y., Chang, C., Tai, C.-M., Tseng, C., Lo, G., Perng, D., Lin, J.-T., & Mo, L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku041 · Cited by 51
Lee, M., Huang, Y., Chen, H., Khor, S., Chang, Y., Lin, Y., Jen, C., Lu, S., Yang, H., Nishida, N., et al. (2017) · Hepatology · doi:10.1002/hep.29531 · Cited by 49
Ahn, J. C., Lim, J. K., Lee, H. M., Lok, A. S.-F., Nguyen, M. H., Pan, C. Q., Mannalithara, A., Te, H. S., Reddy, K. R., Trinh, H. N., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.257 · Cited by 48
Have incidence rates of liver cancer peaked in the United States?
Petrick, J. L., Florio, A. A., Loomba, R. S., & McGlynn, K. A. (2020) · Cancer · doi:10.1002/cncr.32794 · Cited by 48
Self-citationZhang, X., El‐Serag, H. B., & Thrift, A. P. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1052 · Cited by 47
Self-citationAbdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project
Florio, A. A., Campbell, P. T., Zhang, X., Zeleniuch‐Jacquotte, A., Wactawski‐Wende, J., Smith‐Warner, S. A., Sinha, R. R., Simon, T. G., Sesso, H. D., Schairer, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32760 · Cited by 45
Self-citationAdiposity across the adult life course and incidence of primary liver cancer: The NIH‐AARP cohort
Yang, B., Petrick, J. L., Kelly, S. P., Graubard, B. I., Freedman, N. D., & McGlynn, K. A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30737 · Cited by 44
Self-citationTran, K., Coleman, H. G., McCain, R. S., & Cardwell, C. R. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1609053 · Cited by 43
Huang, Z., Guo, X., Zhang, G., Liang, L., & Nong, B. (2019) · The International Journal of Biological Markers · doi:10.1177/1724600818812471 · Cited by 42
Female Sex and the Risk of Liver Cirrhosis
Corrao, G., Aricò, S., Zambon, A., Torchio, P., & di Orio, F. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709002999 · Cited by 39
Lin, Y., Yu, M., Lin, S., Lee, S., Chen, C., Chen, D., & Chen, P. (2017) · Cancer · doi:10.1002/cncr.30851 · Cited by 32
Cited by
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197
Self-citationAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
Yeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., et al. (2023) · doi:10.1101/2023.02.06.23285449 · Cited by 666
Yeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., et al. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0089 · Cited by 662
Is early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 603
Metadata
- Authors
- McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B.
- Venue
- Hepatology
- Published
- 2020-11-24
- Volume
- 73
- Issue
- S1
- Pages
- 4-13
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3021610682
- Cited by
- 2,147
- References
- 86
- FWCI
- 135.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.